Dr. Senada Arabelovic, DO

Dr. Arabelovic practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Arabelovic's NPI, 1053340950, was assigned on July 2, 2006. Dr. Arabelovic graduated from Chicago College of Osteopathic Medicine at Midwestern University in 1997. Dr. Arabelovic holds Massachusetts license 203357.

Dr. Arabelovic's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Arabelovic's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Arabelovic is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Arabelovic to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arabelovic practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Arabelovic's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Arabelovic is board certified in rheumatology by the American Board of Internal Medicine. Dr. Arabelovic is licensed in Massachusetts.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Arabelovic treats.

CMS data shows 440 Medicare services from Dr. Arabelovic across 5 procedure codes in 2024, for 255 Medicare patients. Medicare paid $45,632 for them.

CMS counts 255 Medicare patients who saw Dr. Arabelovic in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have arthritis, and 74% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arabelovic's median patient age at 64, with 72% women.

In 2024, Dr. Arabelovic wrote 1,389 Medicare Part D claims for 194 patients. 71% of them were for generic drugs. CMS names the drug for 1,233 of them, across 29 drugs with 11 or more claims each, at $2,261,574 in total drug cost. In 2023, CMS named 1,008 claims across 27 drugs.

Dr. Arabelovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arabelovic as offering telehealth.

Dmand AI links 9 papers to Dr. Arabelovic, published from 2013 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Antirheumatic Agents, Arthritis, Rheumatoid and Immune Checkpoint Inhibitors. Dr. Arabelovic's most frequent co-authors are Lindsey Adair MacFarlane, MD, Jeffrey A. Sparks, MD and Elizabeth I. Buchbinder, MD.

CMS Open Payments shows 75 general payments to Dr. Arabelovic from 13 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $292.

Dmand AI lists 2 awards for Dr. Arabelovic, most recently CMS Stage 1 EHR in 2013.

Dr. Arabelovic graduated from Chicago College of Osteopathic Medicine at Midwestern University in 1997.

Dr. Arabelovic is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.